menu ☰
menu ˟

[Correspondence] GRECCAR2 trial: details worthy of more attention

13 Jan 2018

We read with great interest the GRECCAR 2 trial by Eric Rullier and colleagues (July 29, 2017, p 469),1 which reported that local excision showed no superiority over total mesorectal excision in rectal cancer patients with a good response after chemoradiotherapy. However, some aspects of the study warrant closer attention.

Click here to view the full article which appeared in The Lancet

IPH Logo